Search clinical trials for: Tazarotene Cream, 0.05%

Total 3976 results

G & W Laboratories Inc.

Completed

Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
Fougera Pharmaceuticals Inc.

Completed

A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
Arcutis Biotherapeutics, Inc.

Completed

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

Atopic Dermatitis (Eczema)

United States
Arcutis Biotherapeutics, Inc.

Completed

Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-OLE)

Atopic Dermatitis Eczema

United States, Canada
Dermatology Consulting Services, PLLC

Completed

Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis

Psoriasis Vulgaris

United States
Arcutis Biotherapeutics, Inc.

Completed

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Psoriasis

Canada, United States
Dermatology Consulting Services, PLLC
Ortho Dermatologics

Completed

A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis

Scalp Psoriasis

United States
G & W Laboratories Inc.

Completed

Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Valeant Pharmaceuticals

Unknown

Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

Acne Vulgaris
Galderma R&D

Completed

Dose Range Study of CD5789 in Acne Vulgaris

Acne Vulgaris

United States
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

Plaque Psoriasis | Palmoplantar Psoriasis

United States
Assiut University

Unknown

Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease

Nail Psoriasis
Cara Therapeutics, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KIND-1)

Pruritus | Atopic Dermatitis

United States
Northwestern University
Bayer

Terminated

Sorafenib-induced Hand- Foot Skin Reaction Treatment

Rash | Hand-foot Skin Reaction

United States
Eisai Limited

Completed

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Eisai Inc.

Completed

Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

Chronic Plaque Psoriasis

United States
Dr. Reddy's Laboratories Limited

Completed

A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris

Acne Vulgaris

United States
McGill University

Unknown

Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study

Cutaneous T-Cell Lymphoma

Canada
Dr. Emmy Graber

Completed

Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne

Erythema | Acne Vulgaris | Skin Scarring | Post Inflammatory Hyperpigmentation | Post Inflammatory Pigmentation Change

United States
Dr. Reddy's Laboratories Limited

Completed

A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris

Acne Vulgaris

United States
University of Utah

Completed

Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna

Cancer | Lentigo Maligna

United States
Jinnah Postgraduate Medical Centre

Completed

Comparison Of Efficacy Of Tazarotene 0.045% Vs Halobetasol Propionate 0.01% Lotion For Treatment of Scalp Psoriasis

Scalp Psoriasis

Pakistan
Allergan

Completed

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.

Plaque Psoriasis

United States
GlaxoSmithKline

Completed

A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

Dermatitis, Atopic

United States, Canada, Japan
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
GlaxoSmithKline

Completed

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

Psoriasis

United States, Canada, Japan
Promius Pharma, LLC

Completed

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis (HPA axis)

Psoriasis

United States
NeoStrata Company, Inc.
Massachusetts General Hospital

Unknown

Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis

Eczema | Dermatitis, Atopic

United States
Galderma R&D

Completed

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Acne Vulgaris

United States
Bausch Health Americas, Inc.

Completed

Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream

Acne

United States
Procter & Gamble Beauty

Completed

Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

Eczema | Dermatitis, Atopic

United States
Pfizer

Completed

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Plaque Psoriasis | Atopic Dermatitis

United States, Canada, United Kingdom, Japan
Aileron Therapeutics, Inc.

Completed

Phase 1 Safety Study of ALRN-5281 in Healthy Subjects

Growth Hormone Deficiency

United States
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Psoriasis

United States
Austin Institute for Clinical Research
OrthoDermatologics

Recruiting

Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults

Plaque Psoriasis

United States
Integro Theranostics

Recruiting

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Breast Cancer | DCIS | Invasive Duct Carcinoma of Breast

United States
Incyte Corporation

Completed

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion

Arsenical Keratosis

Bangladesh
Astion Pharma A/S

Completed

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)

Discoid Lupus Erythematosus

Denmark
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
AstraZeneca

Completed

Topical Roflumilast in Adults With Atopic Dermatitis

Atopic Dermatitis

Germany
Amazentis SA
proDERM GmbH

Completed

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

Skin Aging

Germany
Amazentis SA
proDERM GmbH

Completed

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

Erythema | Skin Inflammation | Sun Damaged Skin

Germany
Allergan

Completed

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

Healthy
Fougera Pharmaceuticals Inc.

Completed

A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Procter and Gamble

Completed

8-Week Atopic Dermatitis (AD) Treatment Study

Atopic Dermatitis Eczema

United States

3

Subscribe